ClinicalTrials.gg
Sign In

Congenital Hyperinsulinism clinical trials

The registry lists 38 studies for Congenital Hyperinsulinism across more than 10 countries. 6 are recruiting or about to start. 34 of them are mainly about Congenital Hyperinsulinism (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-31. Counting its narrower condition Nesidioblastosis too: 39 studies, 5 open.

Get an email when these change. Save the Congenital Hyperinsulinism studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
23
Recruiting
4
Active, not recruiting
3
Status unknown
2
No longer available
2
Not yet recruiting
1

Phase

Phase 2
16
Phase 1
7
Phase 3
6
Phase 4
1

Where

United States
24
United Kingdom
7
Germany
7
Israel
6
Denmark
4
Canada
3

Who runs them

Zealand Pharma (3) · Diva De Leon (3) · Children's Hospital of Philadelphia (3) · Xeris Pharmaceuticals (2) · Montefiore Medical Center (2) · University of Minnesota (2) · University of Alberta (2) · Rezolute (2)

What is being tested here

Drugs under test in Congenital Hyperinsulinism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Fluorodopa F 18225
Dasiglucagon035
Avexitide004
Ersodetug012
Pasireotide002
Glucagon002
HM15136001
Lanreotide Long-Acting Aqueous Gel001
Exenatide001

Coming up

2phase 3 studies under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 4 Congenital Hyperinsulinism studies recruiting now, 2 (50%) set no upper age limit and 2 (50%) stop at 75 or younger. 3 (75%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.

Recruiting studies that take each age, of 4
AgeWomenMen
103 (75%)3 (75%)
184 (100%)4 (100%)
302 (50%)2 (50%)
402 (50%)2 (50%)
502 (50%)2 (50%)
652 (50%)2 (50%)
752 (50%)2 (50%)
852 (50%)2 (50%)

Across all 38 studies, recruiting or not: 66% stop at 75 or younger and 55% at 65; 66% take children; 0% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 38 of 38. search them.